Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables - Roberts, Andrew W.; Ma, Shuo; Kipps, Thomas J.; Coutre, Steven E.; Davids, Matthew S.; Eichhorst, Barbara; Hallek, Michael; Byrd, John C.; Humphrey, Kathryn; Zhou, Lang; Chyla, Brenda; Nielsen, Jacqueline; et al. (Blood, 2019)
Keywords: Adult; Aged; Aged, 80 and over; Antineoplastic Agents - therapeutic use; Bridged Bicyclo Compounds, Heterocyclic - therapeutic use; Clinical Trials and Observations; Female; Humans; Kaplan-Meier Estimate; Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy; Leukemia, Lymphocytic, Chronic, B-Cell - mortality; Leukemia, Lymphocytic, Chronic, B-Cell - pathology; Male; Middle Aged; Neoplasm Recurrence, Local - drug therapy; Progression-Free Survival; Sulfonamides - therapeutic use